

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 7.87615351 |
| 2 | viral transcription (GO:0019083) | 7.72335393 |
| 3 | ribosomal small subunit biogenesis (GO:0042274) | 7.46131098 |
| 4 | ATP synthesis coupled proton transport (GO:0015986) | 7.43208077 |
| 5 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 7.43208077 |
| 6 | translational termination (GO:0006415) | 7.39031529 |
| 7 | ribosomal small subunit assembly (GO:0000028) | 6.82551043 |
| 8 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 6.74143966 |
| 9 | cotranslational protein targeting to membrane (GO:0006613) | 6.71897586 |
| 10 | protein targeting to ER (GO:0045047) | 6.70007551 |
| 11 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 6.42769637 |
| 12 | protein localization to endoplasmic reticulum (GO:0070972) | 6.30456284 |
| 13 | translational elongation (GO:0006414) | 6.12058890 |
| 14 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.92906036 |
| 15 | viral life cycle (GO:0019058) | 5.87069689 |
| 16 | respiratory electron transport chain (GO:0022904) | 5.75058028 |
| 17 | cellular protein complex disassembly (GO:0043624) | 5.69953214 |
| 18 | electron transport chain (GO:0022900) | 5.59001806 |
| 19 | translational initiation (GO:0006413) | 5.35691410 |
| 20 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 5.29222963 |
| 21 | maturation of SSU-rRNA (GO:0030490) | 5.24387419 |
| 22 | ribosomal large subunit biogenesis (GO:0042273) | 4.76590405 |
| 23 | protein complex disassembly (GO:0043241) | 4.72801465 |
| 24 | protein neddylation (GO:0045116) | 4.66991550 |
| 25 | protein targeting to membrane (GO:0006612) | 4.63928202 |
| 26 | translation (GO:0006412) | 4.62735015 |
| 27 | macromolecular complex disassembly (GO:0032984) | 4.44802979 |
| 28 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.26786652 |
| 29 | proteasome assembly (GO:0043248) | 4.24321430 |
| 30 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.81226223 |
| 31 | regulation of mitochondrial translation (GO:0070129) | 3.76580146 |
| 32 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.70146228 |
| 33 | cytochrome complex assembly (GO:0017004) | 3.64748288 |
| 34 | termination of RNA polymerase III transcription (GO:0006386) | 3.58980875 |
| 35 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.58980875 |
| 36 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.56727615 |
| 37 | inner mitochondrial membrane organization (GO:0007007) | 3.55904269 |
| 38 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.51386664 |
| 39 | ATP biosynthetic process (GO:0006754) | 3.50515596 |
| 40 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.48610326 |
| 41 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.43224016 |
| 42 | GTP biosynthetic process (GO:0006183) | 3.41941880 |
| 43 | hydrogen ion transmembrane transport (GO:1902600) | 3.41611734 |
| 44 | chaperone-mediated protein transport (GO:0072321) | 3.40843132 |
| 45 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.39926991 |
| 46 | negative regulation of ligase activity (GO:0051352) | 3.39926991 |
| 47 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.39924006 |
| 48 | respiratory chain complex IV assembly (GO:0008535) | 3.34967315 |
| 49 | mRNA catabolic process (GO:0006402) | 3.32526803 |
| 50 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.32504234 |
| 51 | NADH dehydrogenase complex assembly (GO:0010257) | 3.32504234 |
| 52 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.32504234 |
| 53 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.32159436 |
| 54 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.31845843 |
| 55 | establishment of protein localization to membrane (GO:0090150) | 3.27992346 |
| 56 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.26505069 |
| 57 | protein complex biogenesis (GO:0070271) | 3.26213903 |
| 58 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.24497829 |
| 59 | rRNA modification (GO:0000154) | 3.22375754 |
| 60 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.20315207 |
| 61 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.20315207 |
| 62 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.17165239 |
| 63 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.17165239 |
| 64 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.17165239 |
| 65 | response to interferon-beta (GO:0035456) | 3.16599963 |
| 66 | protein targeting (GO:0006605) | 3.14538863 |
| 67 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.11813641 |
| 68 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.11813641 |
| 69 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.10335906 |
| 70 | cytidine catabolic process (GO:0006216) | 3.08381311 |
| 71 | cytidine deamination (GO:0009972) | 3.08381311 |
| 72 | cytidine metabolic process (GO:0046087) | 3.08381311 |
| 73 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.08132994 |
| 74 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.07483245 |
| 75 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.06047933 |
| 76 | aerobic respiration (GO:0009060) | 3.03448391 |
| 77 | GDP-mannose metabolic process (GO:0019673) | 3.02494055 |
| 78 | oxidative phosphorylation (GO:0006119) | 3.01972899 |
| 79 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.01298041 |
| 80 | cellular component biogenesis (GO:0044085) | 3.00104924 |
| 81 | sequestering of actin monomers (GO:0042989) | 2.98273980 |
| 82 | 7-methylguanosine mRNA capping (GO:0006370) | 2.97872751 |
| 83 | UTP biosynthetic process (GO:0006228) | 2.95998597 |
| 84 | RNA catabolic process (GO:0006401) | 2.95725545 |
| 85 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.95679035 |
| 86 | proton transport (GO:0015992) | 2.95634226 |
| 87 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.94627534 |
| 88 | platelet dense granule organization (GO:0060155) | 2.93512394 |
| 89 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.92284114 |
| 90 | protein targeting to mitochondrion (GO:0006626) | 2.90819051 |
| 91 | 7-methylguanosine RNA capping (GO:0009452) | 2.90791629 |
| 92 | RNA capping (GO:0036260) | 2.90791629 |
| 93 | establishment of protein localization to mitochondrion (GO:0072655) | 2.87694178 |
| 94 | hydrogen transport (GO:0006818) | 2.87480272 |
| 95 | regulation of oxidative phosphorylation (GO:0002082) | 2.84099617 |
| 96 | deoxyribonucleotide catabolic process (GO:0009264) | 2.83902648 |
| 97 | neutrophil activation involved in immune response (GO:0002283) | 2.83485295 |
| 98 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.83410647 |
| 99 | purine nucleotide salvage (GO:0032261) | 2.80830898 |
| 100 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.79214175 |
| 101 | cellular response to interferon-beta (GO:0035458) | 2.77262158 |
| 102 | muscle filament sliding (GO:0030049) | 2.76159086 |
| 103 | actin-myosin filament sliding (GO:0033275) | 2.76159086 |
| 104 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.75853537 |
| 105 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.75853537 |
| 106 | establishment of protein localization to organelle (GO:0072594) | 2.75540690 |
| 107 | DNA deamination (GO:0045006) | 2.75232140 |
| 108 | hydrogen peroxide catabolic process (GO:0042744) | 2.74957976 |
| 109 | positive regulation of ligase activity (GO:0051351) | 2.74318256 |
| 110 | rRNA processing (GO:0006364) | 2.73594443 |
| 111 | protein maturation by protein folding (GO:0022417) | 2.72718230 |
| 112 | mitochondrial transport (GO:0006839) | 2.71831478 |
| 113 | aldehyde catabolic process (GO:0046185) | 2.64856990 |
| 114 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.64105388 |
| 115 | protein localization to mitochondrion (GO:0070585) | 2.62185459 |
| 116 | formation of translation preinitiation complex (GO:0001731) | 2.62169473 |
| 117 | heart process (GO:0003015) | 2.61908435 |
| 118 | heart contraction (GO:0060047) | 2.61908435 |
| 119 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.61765426 |
| 120 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.60437006 |
| 121 | positive regulation of cell cycle arrest (GO:0071158) | 2.59932788 |
| 122 | sarcomere organization (GO:0045214) | 2.58701837 |
| 123 | rRNA metabolic process (GO:0016072) | 2.58010519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.65743713 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.07482378 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.04813554 |
| 4 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.67320854 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.54059438 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.46518530 |
| 7 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.42478547 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.37976827 |
| 9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.32897994 |
| 10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.23933609 |
| 11 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.23770869 |
| 12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.12521790 |
| 13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.87123139 |
| 14 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.78308705 |
| 15 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.42729533 |
| 16 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.42399738 |
| 17 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.38320863 |
| 18 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.33202878 |
| 19 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.30707602 |
| 20 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.29899324 |
| 21 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.28744367 |
| 22 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.12715141 |
| 23 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.11360224 |
| 24 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.03736011 |
| 25 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.02247874 |
| 26 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.00958558 |
| 27 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.97032429 |
| 28 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.95207024 |
| 29 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.91928896 |
| 30 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.89212658 |
| 31 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.85097394 |
| 32 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.83678548 |
| 33 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.79640470 |
| 34 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.77301608 |
| 35 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.67854074 |
| 36 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.63102612 |
| 37 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.60435311 |
| 38 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.59705171 |
| 39 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.59515779 |
| 40 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.54113373 |
| 41 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.53850540 |
| 42 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.53197234 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50886723 |
| 44 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.46152655 |
| 45 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43266521 |
| 46 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.43259536 |
| 47 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42278214 |
| 48 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.41037704 |
| 49 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.41001958 |
| 50 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.38342660 |
| 51 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.26888852 |
| 52 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.26084670 |
| 53 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.25324250 |
| 54 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.24535438 |
| 55 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.24148525 |
| 56 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.24116866 |
| 57 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.22170156 |
| 58 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.22105380 |
| 59 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.21957120 |
| 60 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.21804054 |
| 61 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.21221757 |
| 62 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.19955843 |
| 63 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19171135 |
| 64 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.16122294 |
| 65 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.14406342 |
| 66 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.13567845 |
| 67 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.13296056 |
| 68 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.12487365 |
| 69 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.10094428 |
| 70 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.10015068 |
| 71 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.07914597 |
| 72 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.07309334 |
| 73 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05844463 |
| 74 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.05689960 |
| 75 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.04521787 |
| 76 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.03359592 |
| 77 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.03184721 |
| 78 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03158643 |
| 79 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.02893103 |
| 80 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.02304761 |
| 81 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.01920529 |
| 82 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.01581963 |
| 83 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01049573 |
| 84 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99909418 |
| 85 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.99610021 |
| 86 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.97524334 |
| 87 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.97230240 |
| 88 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.96325343 |
| 89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96102045 |
| 90 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.95941813 |
| 91 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.94686511 |
| 92 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.93383974 |
| 93 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.92613298 |
| 94 | * TFEB_21752829_ChIP-Seq_HELA_Human | 0.92269710 |
| 95 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92185930 |
| 96 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.92142737 |
| 97 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.92104213 |
| 98 | P300_27268052_Chip-Seq_Bcells_Human | 0.92010695 |
| 99 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.90811052 |
| 100 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90411974 |
| 101 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.88143709 |
| 102 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.87608279 |
| 103 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.87576150 |
| 104 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87338035 |
| 105 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.86992758 |
| 106 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.86806460 |
| 107 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.86687307 |
| 108 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85505315 |
| 109 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.85186029 |
| 110 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84995143 |
| 111 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.84931307 |
| 112 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84573325 |
| 113 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.84080177 |
| 114 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.83851477 |
| 115 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.83712875 |
| 116 | MAF_26560356_Chip-Seq_TH2_Human | 0.83152242 |
| 117 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.82681076 |
| 118 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.82052173 |
| 119 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.81958637 |
| 120 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.81129846 |
| 121 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.81018210 |
| 122 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.80787711 |
| 123 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.80764644 |
| 124 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.79036686 |
| 125 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.78860341 |
| 126 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.78297323 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 4.36091313 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 3.81511945 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 3.10957947 |
| 4 | MP0000750_abnormal_muscle_regeneration | 2.45175729 |
| 5 | MP0005464_abnormal_platelet_physiology | 2.39554744 |
| 6 | MP0004084_abnormal_cardiac_muscle | 2.34306063 |
| 7 | MP0000749_muscle_degeneration | 2.23383887 |
| 8 | MP0005451_abnormal_body_composition | 2.21108075 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.17213957 |
| 10 | MP0003646_muscle_fatigue | 2.10809049 |
| 11 | MP0003186_abnormal_redox_activity | 2.10438004 |
| 12 | MP0003950_abnormal_plasma_membrane | 2.07253289 |
| 13 | MP0005058_abnormal_lysosome_morphology | 1.96119227 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 1.89623709 |
| 15 | MP0005330_cardiomyopathy | 1.84463070 |
| 16 | MP0005084_abnormal_gallbladder_morpholo | 1.77924332 |
| 17 | MP0003724_increased_susceptibility_to | 1.77701689 |
| 18 | MP0000343_altered_response_to | 1.76122850 |
| 19 | MP0006082_CNS_inflammation | 1.74381980 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 1.73664654 |
| 21 | MP0001542_abnormal_bone_strength | 1.73061027 |
| 22 | MP0003693_abnormal_embryo_hatching | 1.71392095 |
| 23 | MP0004036_abnormal_muscle_relaxation | 1.68875419 |
| 24 | MP0000751_myopathy | 1.68397699 |
| 25 | MP0006036_abnormal_mitochondrial_physio | 1.64951962 |
| 26 | MP0008875_abnormal_xenobiotic_pharmacok | 1.62892977 |
| 27 | MP0003718_maternal_effect | 1.53769873 |
| 28 | MP0009785_altered_susceptibility_to | 1.52984104 |
| 29 | MP0004957_abnormal_blastocyst_morpholog | 1.48690495 |
| 30 | MP0001727_abnormal_embryo_implantation | 1.48597172 |
| 31 | MP0003786_premature_aging | 1.47029478 |
| 32 | MP0004019_abnormal_vitamin_homeostasis | 1.45570575 |
| 33 | MP0005408_hypopigmentation | 1.44205854 |
| 34 | MP0001800_abnormal_humoral_immune | 1.43652699 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.41971550 |
| 36 | MP0001873_stomach_inflammation | 1.41814493 |
| 37 | MP0002295_abnormal_pulmonary_circulatio | 1.40905792 |
| 38 | MP0005275_abnormal_skin_tensile | 1.39233024 |
| 39 | MP0005365_abnormal_bile_salt | 1.39206669 |
| 40 | MP0001835_abnormal_antigen_presentation | 1.38463392 |
| 41 | MP0003436_decreased_susceptibility_to | 1.37930113 |
| 42 | MP0003303_peritoneal_inflammation | 1.37348845 |
| 43 | MP0003221_abnormal_cardiomyocyte_apopto | 1.36550113 |
| 44 | MP0003806_abnormal_nucleotide_metabolis | 1.36385222 |
| 45 | MP0003828_pulmonary_edema | 1.35840086 |
| 46 | MP0005503_abnormal_tendon_morphology | 1.34185216 |
| 47 | MP0005000_abnormal_immune_tolerance | 1.32686654 |
| 48 | MP0005075_abnormal_melanosome_morpholog | 1.29793780 |
| 49 | MP0002933_joint_inflammation | 1.29686408 |
| 50 | MP0005025_abnormal_response_to | 1.28146402 |
| 51 | MP0008932_abnormal_embryonic_tissue | 1.27289252 |
| 52 | MP0010155_abnormal_intestine_physiology | 1.23450346 |
| 53 | MP0001764_abnormal_homeostasis | 1.22334533 |
| 54 | MP0004185_abnormal_adipocyte_glucose | 1.21073413 |
| 55 | MP0002106_abnormal_muscle_physiology | 1.21014532 |
| 56 | MP0004510_myositis | 1.20830314 |
| 57 | MP0005332_abnormal_amino_acid | 1.20773073 |
| 58 | MP0001544_abnormal_cardiovascular_syste | 1.20442852 |
| 59 | MP0005385_cardiovascular_system_phenoty | 1.20442852 |
| 60 | MP0003279_aneurysm | 1.20379093 |
| 61 | MP0004272_abnormal_basement_membrane | 1.20137071 |
| 62 | MP0005636_abnormal_mineral_homeostasis | 1.17257211 |
| 63 | MP0003075_altered_response_to | 1.15999532 |
| 64 | MP0002972_abnormal_cardiac_muscle | 1.14503501 |
| 65 | MP0002419_abnormal_innate_immunity | 1.14318606 |
| 66 | MP0001958_emphysema | 1.13772954 |
| 67 | MP0003638_abnormal_response/metabolism_ | 1.13729573 |
| 68 | MP0009643_abnormal_urine_homeostasis | 1.13241855 |
| 69 | MP0004087_abnormal_muscle_fiber | 1.12222980 |
| 70 | MP0005083_abnormal_biliary_tract | 1.11666792 |
| 71 | MP0000858_altered_metastatic_potential | 1.10818274 |
| 72 | MP0001533_abnormal_skeleton_physiology | 1.09924186 |
| 73 | MP0005257_abnormal_intraocular_pressure | 1.07990696 |
| 74 | MP0002163_abnormal_gland_morphology | 1.07874674 |
| 75 | MP0002653_abnormal_ependyma_morphology | 1.06928879 |
| 76 | MP0005085_abnormal_gallbladder_physiolo | 1.05278309 |
| 77 | MP0000716_abnormal_immune_system | 1.05227450 |
| 78 | MP0003315_abnormal_perineum_morphology | 1.04920839 |
| 79 | MP0009763_increased_sensitivity_to | 1.04666987 |
| 80 | MP0002254_reproductive_system_inflammat | 1.04663199 |
| 81 | MP0003866_abnormal_defecation | 1.04196956 |
| 82 | MP0000490_abnormal_crypts_of | 1.03240861 |
| 83 | MP0004215_abnormal_myocardial_fiber | 1.03090545 |
| 84 | MP0002398_abnormal_bone_marrow | 1.02206337 |
| 85 | MP0000372_irregular_coat_pigmentation | 1.01777405 |
| 86 | MP0005360_urolithiasis | 1.00890614 |
| 87 | MP0009764_decreased_sensitivity_to | 1.00736402 |
| 88 | MP0008995_early_reproductive_senescence | 1.00394418 |
| 89 | MP0002876_abnormal_thyroid_physiology | 1.00376989 |
| 90 | MP0002429_abnormal_blood_cell | 1.00224641 |
| 91 | MP0005410_abnormal_fertilization | 1.00172811 |
| 92 | MP0005379_endocrine/exocrine_gland_phen | 0.99790267 |
| 93 | MP0003136_yellow_coat_color | 0.99668551 |
| 94 | MP0001881_abnormal_mammary_gland | 0.99276589 |
| 95 | MP0003137_abnormal_impulse_conducting | 0.97815163 |
| 96 | MP0005319_abnormal_enzyme/_coenzyme | 0.97762407 |
| 97 | MP0002405_respiratory_system_inflammati | 0.96734367 |
| 98 | MP0008058_abnormal_DNA_repair | 0.95848390 |
| 99 | MP0000689_abnormal_spleen_morphology | 0.95789272 |
| 100 | MP0003448_altered_tumor_morphology | 0.95458211 |
| 101 | MP0006138_congestive_heart_failure | 0.95158372 |
| 102 | MP0009840_abnormal_foam_cell | 0.94955699 |
| 103 | MP0005369_muscle_phenotype | 0.94385805 |
| 104 | MP0001756_abnormal_urination | 0.93547187 |
| 105 | MP0005165_increased_susceptibility_to | 0.91746348 |
| 106 | MP0005164_abnormal_response_to | 0.91163180 |
| 107 | MP0003567_abnormal_fetal_cardiomyocyte | 0.90820940 |
| 108 | MP0002132_abnormal_respiratory_system | 0.90735906 |
| 109 | MP0001905_abnormal_dopamine_level | 0.90310301 |
| 110 | MP0002452_abnormal_antigen_presenting | 0.90218702 |
| 111 | MP0008775_abnormal_heart_ventricle | 0.89503071 |
| 112 | MP0001663_abnormal_digestive_system | 0.89414778 |
| 113 | MP0000685_abnormal_immune_system | 0.89342908 |
| 114 | MP0002722_abnormal_immune_system | 0.88795735 |
| 115 | MP0005387_immune_system_phenotype | 0.88722201 |
| 116 | MP0001790_abnormal_immune_system | 0.88722201 |
| 117 | MP0000759_abnormal_skeletal_muscle | 0.87931468 |
| 118 | MP0001853_heart_inflammation | 0.87268128 |
| 119 | MP0004145_abnormal_muscle_electrophysio | 0.87042052 |
| 120 | MP0000920_abnormal_myelination | 0.86716924 |
| 121 | MP0002723_abnormal_immune_serum | 0.84611888 |
| 122 | MP0005620_abnormal_muscle_contractility | 0.83448262 |
| 123 | MP0003566_abnormal_cell_adhesion | 0.83021398 |
| 124 | MP0003011_delayed_dark_adaptation | 0.82937627 |
| 125 | MP0003077_abnormal_cell_cycle | 0.82545713 |
| 126 | MP0003191_abnormal_cellular_cholesterol | 0.82397678 |
| 127 | MP0008872_abnormal_physiological_respon | 0.82239741 |
| 128 | MP0006072_abnormal_retinal_apoptosis | 0.82063367 |
| 129 | MP0002693_abnormal_pancreas_physiology | 0.81380036 |
| 130 | MP0001243_abnormal_dermal_layer | 0.81232816 |
| 131 | MP0002277_abnormal_respiratory_mucosa | 0.81199112 |
| 132 | MP0000747_muscle_weakness | 0.80640987 |
| 133 | MP0002938_white_spotting | 0.80434105 |
| 134 | MP0008469_abnormal_protein_level | 0.79617292 |
| 135 | MP0008004_abnormal_stomach_pH | 0.79586426 |
| 136 | MP0005390_skeleton_phenotype | 0.79522928 |
| 137 | MP0006035_abnormal_mitochondrial_morpho | 0.79213498 |
| 138 | MP0003941_abnormal_skin_development | 0.78932840 |
| 139 | MP0003763_abnormal_thymus_physiology | 0.78478378 |
| 140 | MP0010630_abnormal_cardiac_muscle | 0.78442378 |
| 141 | MP0005645_abnormal_hypothalamus_physiol | 0.78355656 |
| 142 | MP0005310_abnormal_salivary_gland | 0.77426198 |
| 143 | MP0001879_abnormal_lymphatic_vessel | 0.75703274 |
| 144 | MP0001819_abnormal_immune_cell | 0.75438611 |
| 145 | MP0000358_abnormal_cell_content/ | 0.75341742 |
| 146 | MP0010386_abnormal_urinary_bladder | 0.75300147 |
| 147 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.74456342 |
| 148 | MP0001529_abnormal_vocalization | 0.74260282 |
| 149 | MP0002420_abnormal_adaptive_immunity | 0.74092246 |
| 150 | MP0004147_increased_porphyrin_level | 0.72896355 |
| 151 | MP0005166_decreased_susceptibility_to | 0.72432655 |
| 152 | MP0005671_abnormal_response_to | 0.70590199 |
| 153 | MP0001851_eye_inflammation | 0.69511103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.53102880 |
| 2 | Mitochondrial inheritance (HP:0001427) | 5.11020524 |
| 3 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.99569800 |
| 4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.93223726 |
| 5 | Increased hepatocellular lipid droplets (HP:0006565) | 4.68726590 |
| 6 | Acute encephalopathy (HP:0006846) | 4.52902205 |
| 7 | Progressive macrocephaly (HP:0004481) | 4.42176358 |
| 8 | Reticulocytopenia (HP:0001896) | 4.40577419 |
| 9 | Abnormal number of erythroid precursors (HP:0012131) | 4.39610019 |
| 10 | Hepatocellular necrosis (HP:0001404) | 4.33943839 |
| 11 | Lipid accumulation in hepatocytes (HP:0006561) | 4.30770628 |
| 12 | Renal Fanconi syndrome (HP:0001994) | 4.13057204 |
| 13 | Increased CSF lactate (HP:0002490) | 4.12588977 |
| 14 | Hepatic necrosis (HP:0002605) | 4.07908933 |
| 15 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.96798255 |
| 16 | Exertional dyspnea (HP:0002875) | 3.93860019 |
| 17 | Macrocytic anemia (HP:0001972) | 3.86495595 |
| 18 | Increased intramyocellular lipid droplets (HP:0012240) | 3.74232052 |
| 19 | Respiratory failure (HP:0002878) | 3.50811726 |
| 20 | Aplastic anemia (HP:0001915) | 3.49573105 |
| 21 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.47752861 |
| 22 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.45508158 |
| 23 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.45508158 |
| 24 | Increased serum pyruvate (HP:0003542) | 3.43505232 |
| 25 | Abnormality of glycolysis (HP:0004366) | 3.43505232 |
| 26 | Increased muscle lipid content (HP:0009058) | 3.39702300 |
| 27 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.39132761 |
| 28 | Exercise intolerance (HP:0003546) | 3.26238178 |
| 29 | Muscle fiber splitting (HP:0003555) | 3.25586594 |
| 30 | Pallor (HP:0000980) | 3.21164295 |
| 31 | Petechiae (HP:0000967) | 3.15221797 |
| 32 | 3-Methylglutaconic aciduria (HP:0003535) | 3.13222142 |
| 33 | Cerebral edema (HP:0002181) | 3.10038698 |
| 34 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.07118338 |
| 35 | Abnormal hemoglobin (HP:0011902) | 3.05235620 |
| 36 | Premature rupture of membranes (HP:0001788) | 2.94709957 |
| 37 | Generalized aminoaciduria (HP:0002909) | 2.89278257 |
| 38 | Parakeratosis (HP:0001036) | 2.87876163 |
| 39 | Vacuolated lymphocytes (HP:0001922) | 2.78614804 |
| 40 | Multiple enchondromatosis (HP:0005701) | 2.76576128 |
| 41 | Type I transferrin isoform profile (HP:0003642) | 2.73850309 |
| 42 | Respiratory difficulties (HP:0002880) | 2.69222026 |
| 43 | Lactic acidosis (HP:0003128) | 2.64209863 |
| 44 | Oral leukoplakia (HP:0002745) | 2.60226696 |
| 45 | Increased serum lactate (HP:0002151) | 2.57086120 |
| 46 | Ventricular tachycardia (HP:0004756) | 2.56821276 |
| 47 | Abnormality of glycolipid metabolism (HP:0010969) | 2.55846455 |
| 48 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.55846455 |
| 49 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.55846455 |
| 50 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.48519618 |
| 51 | Leukodystrophy (HP:0002415) | 2.45425107 |
| 52 | Abnormality of renal resorption (HP:0011038) | 2.44924935 |
| 53 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.44173977 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.44173977 |
| 55 | Recurrent abscess formation (HP:0002722) | 2.42809893 |
| 56 | Sudden death (HP:0001699) | 2.41789315 |
| 57 | Purpura (HP:0000979) | 2.38257729 |
| 58 | Optic disc pallor (HP:0000543) | 2.37965355 |
| 59 | Amniotic constriction ring (HP:0009775) | 2.35652853 |
| 60 | Abnormality of placental membranes (HP:0011409) | 2.35652853 |
| 61 | Glycosuria (HP:0003076) | 2.35629003 |
| 62 | Abnormality of urine glucose concentration (HP:0011016) | 2.35629003 |
| 63 | Lipoatrophy (HP:0100578) | 2.35103705 |
| 64 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.32486465 |
| 65 | Congenital, generalized hypertrichosis (HP:0004540) | 2.23096494 |
| 66 | Trismus (HP:0000211) | 2.22879641 |
| 67 | Hyperphosphaturia (HP:0003109) | 2.13537458 |
| 68 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.12593906 |
| 69 | Abnormality of macrophages (HP:0004311) | 2.11942349 |
| 70 | Methylmalonic aciduria (HP:0012120) | 2.09842995 |
| 71 | Pancytopenia (HP:0001876) | 2.07694381 |
| 72 | CNS demyelination (HP:0007305) | 2.05921229 |
| 73 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.03816098 |
| 74 | Calf muscle hypertrophy (HP:0008981) | 2.02448472 |
| 75 | Abnormal pupillary function (HP:0007686) | 1.99314292 |
| 76 | Thrombocytosis (HP:0001894) | 1.97811404 |
| 77 | Vertebral compression fractures (HP:0002953) | 1.97394990 |
| 78 | Abnormal urine phosphate concentration (HP:0012599) | 1.93615281 |
| 79 | Increased serum ferritin (HP:0003281) | 1.93088335 |
| 80 | Paralysis (HP:0003470) | 1.93076042 |
| 81 | Nausea (HP:0002018) | 1.92268831 |
| 82 | Hepatosplenomegaly (HP:0001433) | 1.92076383 |
| 83 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.90601075 |
| 84 | Poor head control (HP:0002421) | 1.90571991 |
| 85 | Breast hypoplasia (HP:0003187) | 1.90084800 |
| 86 | Testicular atrophy (HP:0000029) | 1.87794664 |
| 87 | Axonal loss (HP:0003447) | 1.85491182 |
| 88 | Recurrent bacterial skin infections (HP:0005406) | 1.85369457 |
| 89 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.84962014 |
| 90 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.84962014 |
| 91 | Abnormal protein glycosylation (HP:0012346) | 1.84962014 |
| 92 | Abnormal glycosylation (HP:0012345) | 1.84962014 |
| 93 | Systemic lupus erythematosus (HP:0002725) | 1.84309099 |
| 94 | Protrusio acetabuli (HP:0003179) | 1.83843138 |
| 95 | Renal tubular dysfunction (HP:0000124) | 1.81350728 |
| 96 | IgM deficiency (HP:0002850) | 1.80176875 |
| 97 | Eczematoid dermatitis (HP:0000976) | 1.79806584 |
| 98 | Rhabdomyolysis (HP:0003201) | 1.78332826 |
| 99 | Vomiting (HP:0002013) | 1.78313387 |
| 100 | Dilated cardiomyopathy (HP:0001644) | 1.78295530 |
| 101 | Rough bone trabeculation (HP:0100670) | 1.78260689 |
| 102 | Rhinitis (HP:0012384) | 1.78147195 |
| 103 | Increased IgM level (HP:0003496) | 1.78033446 |
| 104 | Abnormality of the umbilical cord (HP:0010881) | 1.77633385 |
| 105 | Sparse eyelashes (HP:0000653) | 1.75094132 |
| 106 | Abnormal ciliary motility (HP:0012262) | 1.75093573 |
| 107 | Abnormality of dentin (HP:0010299) | 1.74602005 |
| 108 | Microvesicular hepatic steatosis (HP:0001414) | 1.74451056 |
| 109 | Carpal bone hypoplasia (HP:0001498) | 1.74231110 |
| 110 | Esophageal neoplasm (HP:0100751) | 1.71344869 |
| 111 | Neoplasm of head and neck (HP:0012288) | 1.71344869 |
| 112 | Methylmalonic acidemia (HP:0002912) | 1.70866930 |
| 113 | Abnormality of the anterior horn cell (HP:0006802) | 1.68705329 |
| 114 | Degeneration of anterior horn cells (HP:0002398) | 1.68705329 |
| 115 | Stomatitis (HP:0010280) | 1.68553894 |
| 116 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.68507663 |
| 117 | Chronic sinusitis (HP:0011109) | 1.68282117 |
| 118 | Reduced antithrombin III activity (HP:0001976) | 1.68218273 |
| 119 | Cerebral hypomyelination (HP:0006808) | 1.67517287 |
| 120 | Secondary amenorrhea (HP:0000869) | 1.67429285 |
| 121 | Abnormality of iron homeostasis (HP:0011031) | 1.67362442 |
| 122 | Type 1 muscle fiber predominance (HP:0003803) | 1.66819726 |
| 123 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.66638710 |
| 124 | Palpitations (HP:0001962) | 1.65041224 |
| 125 | Blindness (HP:0000618) | 1.64525155 |
| 126 | Pulmonary artery stenosis (HP:0004415) | 1.63992372 |
| 127 | Conjunctival hamartoma (HP:0100780) | 1.63830672 |
| 128 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.62943440 |
| 129 | Lethargy (HP:0001254) | 1.62829674 |
| 130 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.62655306 |
| 131 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.62655306 |
| 132 | Stenosis of the external auditory canal (HP:0000402) | 1.62529312 |
| 133 | Abnormality of the calf musculature (HP:0001430) | 1.60784808 |
| 134 | Neutropenia (HP:0001875) | 1.60302213 |
| 135 | Abnormal trabecular bone morphology (HP:0100671) | 1.60044317 |
| 136 | Nemaline bodies (HP:0003798) | 1.60004041 |
| 137 | Progressive neurologic deterioration (HP:0002344) | 1.59236215 |
| 138 | Neck muscle weakness (HP:0000467) | 1.57928871 |
| 139 | Soft skin (HP:0000977) | 1.57484004 |
| 140 | Muscle fiber inclusion bodies (HP:0100299) | 1.57276775 |
| 141 | X-linked dominant inheritance (HP:0001423) | 1.57055605 |
| 142 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.56946426 |
| 143 | Emotional lability (HP:0000712) | 1.56700342 |
| 144 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.56459094 |
| 145 | Chronic obstructive pulmonary disease (HP:0006510) | 1.55695407 |
| 146 | Obstructive lung disease (HP:0006536) | 1.55695407 |
| 147 | Ileus (HP:0002595) | 1.55636646 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 6.19375244 |
| 2 | NME2 | 5.54885116 |
| 3 | PBK | 3.11884236 |
| 4 | BUB1 | 3.06618252 |
| 5 | PIM2 | 2.84055069 |
| 6 | MYLK | 2.75866358 |
| 7 | TESK2 | 2.71179179 |
| 8 | MAP3K12 | 2.50169400 |
| 9 | TLK1 | 2.48762897 |
| 10 | MST4 | 2.40130291 |
| 11 | LIMK1 | 2.24561932 |
| 12 | NME1 | 2.16932657 |
| 13 | STK39 | 2.08481239 |
| 14 | KDR | 1.99945889 |
| 15 | EIF2AK1 | 1.95382175 |
| 16 | STK16 | 1.91641224 |
| 17 | TESK1 | 1.86343228 |
| 18 | IRAK3 | 1.81784428 |
| 19 | BLK | 1.80552245 |
| 20 | ILK | 1.77480043 |
| 21 | TTN | 1.71053685 |
| 22 | OBSCN | 1.70510852 |
| 23 | LRRK2 | 1.66521511 |
| 24 | ARAF | 1.65043121 |
| 25 | BCKDK | 1.64983968 |
| 26 | ABL2 | 1.60664047 |
| 27 | TXK | 1.54421885 |
| 28 | WEE1 | 1.48397933 |
| 29 | WNK4 | 1.48019601 |
| 30 | ADRBK2 | 1.31608202 |
| 31 | DAPK3 | 1.30631878 |
| 32 | IRAK4 | 1.28346359 |
| 33 | EIF2AK3 | 1.22507807 |
| 34 | VRK1 | 1.13914649 |
| 35 | TAOK2 | 1.12941716 |
| 36 | TBK1 | 1.12813781 |
| 37 | GRK6 | 1.12774988 |
| 38 | DYRK2 | 1.08670237 |
| 39 | PLK4 | 1.08160044 |
| 40 | EPHB1 | 1.06832712 |
| 41 | PAK4 | 1.02411769 |
| 42 | RIPK4 | 0.99658819 |
| 43 | GRK1 | 0.98704750 |
| 44 | MUSK | 0.98427692 |
| 45 | MAP2K2 | 0.95957275 |
| 46 | MAP3K3 | 0.95594503 |
| 47 | EPHB2 | 0.94531514 |
| 48 | PAK1 | 0.91339858 |
| 49 | CDK8 | 0.89465231 |
| 50 | SRPK1 | 0.89305326 |
| 51 | MAPK15 | 0.87626795 |
| 52 | BRAF | 0.83423188 |
| 53 | MAP3K11 | 0.82241393 |
| 54 | TAF1 | 0.81067803 |
| 55 | IKBKB | 0.81020237 |
| 56 | PIK3CG | 0.80585158 |
| 57 | DAPK1 | 0.80296172 |
| 58 | STK24 | 0.79521048 |
| 59 | SYK | 0.77395353 |
| 60 | STK4 | 0.77230067 |
| 61 | TYK2 | 0.76112506 |
| 62 | RPS6KA5 | 0.75255317 |
| 63 | FGR | 0.75246407 |
| 64 | MAP4K1 | 0.73723160 |
| 65 | CSF1R | 0.73025211 |
| 66 | CDC7 | 0.71527328 |
| 67 | AURKB | 0.70744896 |
| 68 | MATK | 0.69090835 |
| 69 | ROCK2 | 0.68795131 |
| 70 | KIT | 0.68270018 |
| 71 | GRK7 | 0.67638082 |
| 72 | MAP2K6 | 0.67309944 |
| 73 | ERN1 | 0.67165763 |
| 74 | IRAK1 | 0.66976745 |
| 75 | GRK5 | 0.66907691 |
| 76 | RPS6KB2 | 0.66294379 |
| 77 | ITK | 0.66200901 |
| 78 | BTK | 0.65491817 |
| 79 | TAOK3 | 0.65387715 |
| 80 | IKBKE | 0.64703081 |
| 81 | RPS6KA4 | 0.64682117 |
| 82 | STK38L | 0.64595502 |
| 83 | FES | 0.64292077 |
| 84 | TNK2 | 0.61571956 |
| 85 | AURKA | 0.60021185 |
| 86 | PKN1 | 0.59976977 |
| 87 | TIE1 | 0.59362556 |
| 88 | MAPKAPK5 | 0.57977727 |
| 89 | TRIB3 | 0.57030299 |
| 90 | PIK3CA | 0.56495073 |
| 91 | MOS | 0.56278385 |
| 92 | MAP3K8 | 0.54943237 |
| 93 | TRPM7 | 0.54244460 |
| 94 | NEK9 | 0.54099673 |
| 95 | SCYL2 | 0.50555959 |
| 96 | CSNK2A1 | 0.50372495 |
| 97 | CAMK2D | 0.50307290 |
| 98 | MET | 0.49794188 |
| 99 | DYRK3 | 0.49474310 |
| 100 | ZAK | 0.47930915 |
| 101 | OXSR1 | 0.47633515 |
| 102 | BMX | 0.47139312 |
| 103 | TTK | 0.46331088 |
| 104 | ZAP70 | 0.46023576 |
| 105 | IRAK2 | 0.45884317 |
| 106 | LMTK2 | 0.45729344 |
| 107 | ROCK1 | 0.45715180 |
| 108 | LATS2 | 0.45085398 |
| 109 | PRKD1 | 0.44170633 |
| 110 | CSNK1G3 | 0.44079154 |
| 111 | LYN | 0.43955562 |
| 112 | PIM1 | 0.42929455 |
| 113 | ADRBK1 | 0.42756655 |
| 114 | PRKG2 | 0.42578737 |
| 115 | PRKCD | 0.42230274 |
| 116 | MAPKAPK3 | 0.42205250 |
| 117 | PLK1 | 0.41950607 |
| 118 | PAK2 | 0.41239520 |
| 119 | PRKCQ | 0.41102507 |
| 120 | BCR | 0.40475489 |
| 121 | PRKCI | 0.40418585 |
| 122 | CCNB1 | 0.39756866 |
| 123 | MAP2K3 | 0.39402977 |
| 124 | DDR2 | 0.39331311 |
| 125 | JAK3 | 0.37314398 |
| 126 | CSNK2A2 | 0.37178939 |
| 127 | TEC | 0.36022534 |
| 128 | PDK2 | 0.35798762 |
| 129 | CSK | 0.35224023 |
| 130 | NUAK1 | 0.34284257 |
| 131 | LCK | 0.33412620 |
| 132 | INSRR | 0.33010286 |
| 133 | MAPKAPK2 | 0.32693147 |
| 134 | BMPR1B | 0.30001378 |
| 135 | CHEK2 | 0.26734129 |
| 136 | PLK3 | 0.25701711 |
| 137 | BMPR2 | 0.25024488 |
| 138 | PRKCA | 0.24824060 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.99430612 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 5.14185652 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 4.43636060 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 4.12180814 |
| 5 | Alzheimers disease_Homo sapiens_hsa05010 | 3.29058368 |
| 6 | Huntingtons disease_Homo sapiens_hsa05016 | 3.22897265 |
| 7 | Protein export_Homo sapiens_hsa03060 | 3.19595129 |
| 8 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 3.18116435 |
| 9 | RNA polymerase_Homo sapiens_hsa03020 | 3.13812859 |
| 10 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.27128392 |
| 11 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.68580092 |
| 12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.64201542 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.58751264 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.49537948 |
| 15 | Spliceosome_Homo sapiens_hsa03040 | 1.47599121 |
| 16 | DNA replication_Homo sapiens_hsa03030 | 1.27337745 |
| 17 | Homologous recombination_Homo sapiens_hsa03440 | 1.26468112 |
| 18 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.23956145 |
| 19 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.14307515 |
| 20 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.09508075 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.04955538 |
| 22 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.04529707 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.02697554 |
| 24 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.00860028 |
| 25 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.99662396 |
| 26 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.96380641 |
| 27 | Mismatch repair_Homo sapiens_hsa03430 | 0.93621835 |
| 28 | Basal transcription factors_Homo sapiens_hsa03022 | 0.89247147 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.87260637 |
| 30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.85552398 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.84254941 |
| 32 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.83744435 |
| 33 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.83175613 |
| 34 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.82202512 |
| 35 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.81835786 |
| 36 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.81692263 |
| 37 | Lysosome_Homo sapiens_hsa04142 | 0.80100149 |
| 38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.78430468 |
| 39 | Malaria_Homo sapiens_hsa05144 | 0.77930527 |
| 40 | RNA transport_Homo sapiens_hsa03013 | 0.75730144 |
| 41 | Peroxisome_Homo sapiens_hsa04146 | 0.75431527 |
| 42 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.74592173 |
| 43 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73993977 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.73184129 |
| 45 | Purine metabolism_Homo sapiens_hsa00230 | 0.72285632 |
| 46 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.71531512 |
| 47 | Phagosome_Homo sapiens_hsa04145 | 0.70188816 |
| 48 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.69805295 |
| 49 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.69433294 |
| 50 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.68462718 |
| 51 | Base excision repair_Homo sapiens_hsa03410 | 0.67504563 |
| 52 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.67446214 |
| 53 | Metabolic pathways_Homo sapiens_hsa01100 | 0.66967491 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.65917757 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.64694657 |
| 56 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63596013 |
| 57 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62772527 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.62678842 |
| 59 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.62658013 |
| 60 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.62427116 |
| 61 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.60151541 |
| 62 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.60111334 |
| 63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59903924 |
| 64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.59520018 |
| 65 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.59009355 |
| 66 | Viral myocarditis_Homo sapiens_hsa05416 | 0.58909478 |
| 67 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.57907230 |
| 68 | Asthma_Homo sapiens_hsa05310 | 0.57806080 |
| 69 | Allograft rejection_Homo sapiens_hsa05330 | 0.56066585 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.55774744 |
| 71 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.55751553 |
| 72 | Leishmaniasis_Homo sapiens_hsa05140 | 0.55221424 |
| 73 | RNA degradation_Homo sapiens_hsa03018 | 0.54622742 |
| 74 | Legionellosis_Homo sapiens_hsa05134 | 0.54474305 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.54099739 |
| 76 | Mineral absorption_Homo sapiens_hsa04978 | 0.53834147 |
| 77 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53373202 |
| 78 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.52872816 |
| 79 | Carbon metabolism_Homo sapiens_hsa01200 | 0.52674261 |
| 80 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.51025471 |
| 81 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.50295366 |
| 82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48947420 |
| 83 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.48475080 |
| 84 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.47929805 |
| 85 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.46366635 |
| 86 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.44423621 |
| 87 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.43493642 |
| 88 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.42990112 |
| 89 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.42301439 |
| 90 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.41745686 |
| 91 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.40695971 |
| 92 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.38381693 |
| 93 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37892751 |
| 94 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.37652610 |
| 95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.36973726 |
| 96 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.36816310 |
| 97 | Retinol metabolism_Homo sapiens_hsa00830 | 0.36391017 |
| 98 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.36245995 |
| 99 | Shigellosis_Homo sapiens_hsa05131 | 0.36178668 |
| 100 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.35556357 |
| 101 | Cell cycle_Homo sapiens_hsa04110 | 0.34571134 |
| 102 | Apoptosis_Homo sapiens_hsa04210 | 0.34271368 |
| 103 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34061612 |
| 104 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.33977376 |
| 105 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.33789038 |
| 106 | Salmonella infection_Homo sapiens_hsa05132 | 0.33435799 |
| 107 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.33404659 |
| 108 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.33065793 |
| 109 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.31363409 |
| 110 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.31016838 |
| 111 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.30986309 |
| 112 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.29826573 |
| 113 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.29256653 |
| 114 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.29195315 |
| 115 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.27852255 |
| 116 | Histidine metabolism_Homo sapiens_hsa00340 | 0.25825059 |
| 117 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.25338272 |
| 118 | Tuberculosis_Homo sapiens_hsa05152 | 0.25104057 |
| 119 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.24535389 |
| 120 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.22883175 |
| 121 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.20875375 |
| 122 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.20354345 |
| 123 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.20156423 |
| 124 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.19428029 |
| 125 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.19409818 |
| 126 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.18637246 |
| 127 | Tight junction_Homo sapiens_hsa04530 | 0.16688799 |
| 128 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.16384354 |
| 129 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.15294906 |
| 130 | Amoebiasis_Homo sapiens_hsa05146 | 0.15067544 |

